Intravenous lipid emulsions in the prevention and treatment of liver disease in intestinal failure
FA Rochling - Nutrients, 2021 - mdpi.com
The development of intestinal failure-associated liver disease (IFALD) in pediatric and adult
patients on parenteral nutrition is usually multifactorial in nature due to nutritional and non …
patients on parenteral nutrition is usually multifactorial in nature due to nutritional and non …
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
YY Shao, PS Chen, LI Lin, BS Lee, A Ling… - British Journal of …, 2022 - nature.com
Background Sorafenib is one of the standard first-line therapies for advanced hepatocellular
carcinoma (HCC). Unfortunately, there are currently no appropriate biomarkers to predict the …
carcinoma (HCC). Unfortunately, there are currently no appropriate biomarkers to predict the …
Improving the diagnostic potential of extracellular miRNAs coupled to multiomics data by exploiting the power of artificial intelligence
A Paolini, A Baldassarre, SP Bruno, C Felli… - Frontiers in …, 2022 - frontiersin.org
In recent years, the clinical use of extracellular miRNAs as potential biomarkers of disease
has increasingly emerged as a new and powerful tool. Serum, urine, saliva and stool contain …
has increasingly emerged as a new and powerful tool. Serum, urine, saliva and stool contain …
Inflammation drives pathogenesis of early intestinal failure-associated liver disease
Patients with intestinal failure who receive long-term parenteral nutrition (PN) often develop
intestinal failure-associated liver disease (IFALD). Although there are identified risk factors …
intestinal failure-associated liver disease (IFALD). Although there are identified risk factors …
Comparative analysis of the miRNA-mRNA regulation networks in turbot (Scophthalmus maximus L.) following Vibrio anguillarum infection
C Gao, X Cai, M Cao, Q Fu, N Yang, X Liu… - Developmental & …, 2021 - Elsevier
MicroRNAs could not only regulate posttranscriptional silencing of target genes in eukaryotic
organisms, but also have positive effect on their target genes as well. These microRNAs …
organisms, but also have positive effect on their target genes as well. These microRNAs …
Bilirubin and epigenetic modifications in metabolic and immunometabolic disorders
MM Sarabi, E Babaeenezhad, M Amini… - … Metabolic & Immune …, 2022 - ingentaconnect.com
Bilirubin is the main waste product of heme catabolism. At high concentrations, bilirubin may
cause toxicity, especially in the brain, kidney, and erythrocytes. Membrane and …
cause toxicity, especially in the brain, kidney, and erythrocytes. Membrane and …
Comparison of Mir122 expression in children with biliary atresia and healthy group
N Motazedian, N Azarpira, K Falamarzi… - Molecular Biology …, 2024 - journals.shirazu.ac.ir
Biliary atresia (BA) is the primary cause of neonatal jaundice with various pathological
mechanisms. Many BA patients may experience progressive liver dysfunction and …
mechanisms. Many BA patients may experience progressive liver dysfunction and …
Genética molecular y biomarcadores de la enfermedad de Wilson
A Sánchez Monteagudo - 2023 - riunet.upv.es
[ES] La enfermedad de Wilson (EW) es un trastorno hereditario del metabolismo del cobre
causado por mutaciones en ATP7B, que codifica una proteína transportadora de cobre en el …
causado por mutaciones en ATP7B, que codifica una proteína transportadora de cobre en el …